Recombinant attenuated Salmonella harboring 4-1BB ligand gene enhances cellular immunity
- PMID: 19187795
- DOI: 10.1016/j.vaccine.2009.01.031
Recombinant attenuated Salmonella harboring 4-1BB ligand gene enhances cellular immunity
Abstract
Objective: To transfect antigen presenting cells (APCs) with 4-1BB ligand DNA by attenuated Salmonella enterica serovar Typhimurium in vivo, and to observe the effects of ectogenous 4-1BBL on the immune functions of infected rats.
Methods: Attenuated Salmonella typhimurium (vaccine strain) carrying plasmids pIRES2-EGFP-4-1BBL was constructed and used to infect HepG2 hepatoma cells. The expression of reporter gene, green fluorescent protein (GFP) and rat 4-1BBL in the transfected cells was detected by double-immunofluorescence staining. Rats were fed with the recombinant bacteria intragastrically on three occasions in 2 weeks, and were then sacrificed. The transcription and expression of GFP and 4-1BBL genes in splenocytes were measured by RT-PCR and flow cytometry. The phenotypes of T cells in peripheral blood and splenocytes were determined by flow cytometry. The content of IFN-gamma in the cultural supernatant of splenocytes stimulated by PHA was measured by ELISA.
Results: The recombinant bacteria harboring 4-1BBL had the same invasive abilities as the original bacteria, and it was able to deliver exogenous genes into HepG2 cells, where the GFP and 4-1BBL were successfully expressed. There were significant upregulations of CD3(+)CD8(+) T cells (P=0.018) and CD3(+)CD25(+) T cells (P=0.019) in the peripheral blood cells as well as CD3(+)CD8(+) T cells (P=0.022), and CD3(+)CD25(+) T cells (P=0.008) in splenocytes of the infected rats. The rats had more 4-1BBL expression detected in the spleen. IFN-gamma released by PHA-stimulated splenocytes increased significantly by the recombinant bacteria as compared with controls (P=0.002).
Conclusion: Salmonella serovar Typhimurium containing 4-1BBL can transfect target genes into antigen presenting cells in vivo, and the expression of exogenous 4-1BBL enhances cellular immunity markedly.
Similar articles
-
Recombinant Salmonella-based CEACAM6 and 4-1BBL vaccine enhances T-cell immunity and inhibits the development of colorectal cancer in rats: In vivo effects of vaccine containing 4-1BBL and CEACAM6.Oncol Rep. 2015 Jun;33(6):2837-44. doi: 10.3892/or.2015.3901. Epub 2015 Apr 7. Oncol Rep. 2015. PMID: 25872647
-
[Immunity and EGFPC3 expression of recombinant attenuated salmonella typhimurium carrying plasmid pcDNA3s and EGFPC3 in mice].Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2007 Apr;23(4):299-302. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2007. PMID: 17428380 Chinese.
-
Adoptively transferred tumor-specific T cells stimulated ex vivo using herpes simplex virus amplicons encoding 4-1BBL persist in the host and show antitumor activity in vivo.Cancer Res. 2007 Oct 15;67(20):10027-37. doi: 10.1158/0008-5472.CAN-06-2391. Cancer Res. 2007. PMID: 17942937
-
Improving live attenuated bacterial carriers for vaccination and therapy.Int J Med Microbiol. 2008 Jan;298(1-2):21-6. doi: 10.1016/j.ijmm.2007.07.005. Epub 2007 Aug 16. Int J Med Microbiol. 2008. PMID: 17702649 Review.
-
Salmonella type III-mediated heterologous antigen delivery: a versatile oral vaccination strategy to induce cellular immunity against infectious agents and tumors.Int J Med Microbiol. 2008 Jan;298(1-2):99-103. doi: 10.1016/j.ijmm.2007.07.002. Epub 2007 Aug 23. Int J Med Microbiol. 2008. PMID: 17719275 Review.
Cited by
-
Recombinant human CD137L for cancer immunotherapy: effects of different fusions and linkers on its activity.Cancer Immunol Immunother. 2012 Apr;61(4):489-95. doi: 10.1007/s00262-011-1097-0. Epub 2011 Oct 4. Cancer Immunol Immunother. 2012. PMID: 21968735 Free PMC article.
-
The role of IL‑17, IFN‑γ, 4‑1BBL and tumour‑infiltrating lymphocytes in the occurrence, development and prognosis of pancreatic cancer.Oncol Lett. 2024 Dec 5;29(2):88. doi: 10.3892/ol.2024.14834. eCollection 2025 Feb. Oncol Lett. 2024. PMID: 39677412 Free PMC article.
-
Efficacy of bivalent CEACAM6/4-1BBL genetic vaccine combined with anti-PD1 antibody in MC38 tumor model of mice.Heliyon. 2022 Sep 28;8(10):e10775. doi: 10.1016/j.heliyon.2022.e10775. eCollection 2022 Oct. Heliyon. 2022. PMID: 36212004 Free PMC article.
-
TNFSF9 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Pancreatic Cancer.J Gastrointest Cancer. 2021 Mar;52(1):150-159. doi: 10.1007/s12029-020-00371-6. J Gastrointest Cancer. 2021. PMID: 32077004
-
Recombinant Salmonella-based 4-1BBL vaccine enhances T cell immunity and inhibits the development of colorectal cancer in rats: in vivo effects of vaccine containing 4-1BBL.J Biomed Sci. 2013 Feb 17;20(1):8. doi: 10.1186/1423-0127-20-8. J Biomed Sci. 2013. PMID: 23413971 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous